United states Food and Drugs Administration approved the medication Staxyn (varbenafil HCL) tablets for the treatment of erectile dysfunction. The main advantage of Staxyn is that tablets are quickly dissolved in the mouth cavity under the tongue. Staxyn is made by GlaxoSmithKline and Merck & Co. The medication will be very soon available on US pharmaceutical market. The active ingredient of Staxyn is vardenafil hcl that is the main active component of well known medication Levitra. Vardenafil is PDE5 inhibitor that works by enhancing blood flow to penis causing strong and lasting erection satisfactory for sexual activity. By inhibiting PDE5 vardenafil increases the amount of cyclic GMP in cavernous body and thus relaxes the smooth muscle causing blood inflow to penis. Staxyn will be recommended only for patients over 18 years of age and is not intended to treat women sexual problems.
Staxyn
Staxyn medication must not be using in combination with nitrates which are nitrogen oxide donors. Also the medication is not recommended for use with CYP3A4 inhibitors, alpha-blockers, protease inhibitors and other drugs which interact with Levitra (see Levitra drugs interactions).
It is not recommended to take Staxyn tablets in patients with hypertension, history of heart attacks and strokes (for the last 6 months), unstable angina, degenerative diseases of the retina. Also the medication must not be used in patients with anatomical deformations of the penis.
Staxyn side effects are common for all PDE5 inhibitors and include: headache, hot flashes, dyspepsia, nausea, dizziness, nasal congestion. Less common Staxyn side effects include: increased levels of creatine kinase in the blood, back pain, rhinitis. You can get more information about the vardenafil HERE!
